LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000099 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
3,774
Total Value
$0.00
P&L
+inf% (+$1,209,265.08)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 5, 2026 | Grant/Award | 836 | $0.00 | $0.00 | 31,560 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 5, 2026 | Grant/Award | 2,938 | $0.00 | $0.00 | 2,938 | Direct | โ | View Details |